| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 04/13/2011 | EP2307460A2 Mineral amino acid polysaccharide complex |
| 04/13/2011 | EP2307436A2 Novel detection probe |
| 04/13/2011 | EP1543020B1 Codon optimized synthetic plasmids |
| 04/13/2011 | CN1910293B Detection of mutations in a gene associated with resistance to viral infection, OASI |
| 04/13/2011 | CN102016076A Target amplification and sequencing with primers comprising triplex forming monomer units |
| 04/13/2011 | CN102016039A Aberrant mitochondrial DNA, associated fusion transcripts and hybridization probes therefor |
| 04/13/2011 | CN102016038A Method of evaluating earwax type or underarm odor |
| 04/13/2011 | CN102016036A Modified RNAi polynucleotides and uses thereof |
| 04/13/2011 | CN102016023A Vaccines and immunotherapeutics using IL-28 and compositions and methods of using the same |
| 04/13/2011 | CN102015749A Sequence-specific nucleic acid purification method manner |
| 04/13/2011 | CN102014932A Compositions and methods for inhibiting expression of Eg5 and VEGF genes |
| 04/13/2011 | CN102010463A Consensus/ancestral immunogens |
| 04/12/2011 | US7923608 Tomato hybrid ‘vespolino’ |
| 04/12/2011 | US7923599 Antifungal polypeptides |
| 04/12/2011 | US7923598 Fatty acid hydroxylases and uses thereof |
| 04/12/2011 | US7923551 Method of purifying RNA using kosmotropic salt |
| 04/12/2011 | US7923550 Reagent compounds and methods of making and using the same |
| 04/12/2011 | US7923549 RNA interference mediated inhibition of interleukin and interleukin receptor gene expression using short interfering nucleic acid (siNA) |
| 04/12/2011 | US7923548 Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to Grb2 or Crk1 |
| 04/12/2011 | US7923547 for antisense therapy |
| 04/12/2011 | US7923546 Base sequence for control probe and method of designing the same |
| 04/12/2011 | US7923545 Caterpiller gene family |
| 04/12/2011 | US7923544 Biomarkers for inflammatory bowel disease and irritable bowel syndrome |
| 04/12/2011 | US7923543 Nucleic acid and corresponding protein entitled 162P1E6 useful in treatment and detection of cancer |
| 04/12/2011 | US7923542 Isolating a collection of polynucleotide sequences corresponding to accessible regions of cellular chromatin |
| 04/12/2011 | US7923535 Tryptophan as a functional replacement for ADP-ribose-arginine in recombinant proteins |
| 04/12/2011 | US7923237 Using capacitance variance to detect receptor/biopolymer binding; screening for protein interactions; drug screening and molecular recognition; biochips |
| 04/12/2011 | US7923236 Fungal enzymes |
| 04/12/2011 | US7923235 CIP1 polypeptides and their uses |
| 04/12/2011 | US7923234 Thermal and acid tolerant beta-xylosidases, genes encoding, related organisms, and methods |
| 04/12/2011 | US7923233 Perhydrolase providing improved peracid stability |
| 04/12/2011 | US7923226 Synthesis of 1,2,4-butanetriol enantiomers from carbohydrates |
| 04/12/2011 | US7923225 Method for the enzymatic production of 2-hydroxy-2-methyl carboxylic acids |
| 04/12/2011 | US7923223 nucleotide sequence encoding a polypeptide Delta 9 desaturase enzyme which has the ability to convert palmitic acid or stearic acid into palmitoleic acid or oleic acid respectively |
| 04/12/2011 | US7923222 Methods of using isolated glucose isomerase |
| 04/12/2011 | US7923212 Antibodies to cytokine receptor zalpha11 |
| 04/12/2011 | US7923207 Apparatus and system having dry gene silencing pools |
| 04/12/2011 | US7923206 Method of determining a cellular response to a biological agent |
| 04/12/2011 | US7923015 Methods for direct visualization of active synapses |
| 04/12/2011 | US7922917 Porous ferro- or ferrimagnetic glass particles for isolating molecules |
| 04/12/2011 | US7922483 Method of using a polynucleotide encoding 2.5-diketo-D-gluconic acid reductase |
| 04/12/2011 | CA2434060C Preparation of a therapeutic composition |
| 04/12/2011 | CA2361725C Selection of proteins using rna-protein fusions |
| 04/12/2011 | CA2228769C Method of purifying, stabilising or isolating nucleic acids contained in biological matter |
| 04/07/2011 | WO2011041485A1 Methods for non-invasive prenatal ploidy calling |
| 04/07/2011 | WO2011041327A1 Light controlled protein dimerization in cells |
| 04/07/2011 | WO2011040885A1 A clinical method for genotyping large genes for mutations that potentially cause disease |
| 04/07/2011 | WO2010134992A3 Synthesis labile base protected - modified deoxy & modified ribo nucleosides, corresponding phosphoramidites and supports and their use in high purity oligonucleotide synthesis |
| 04/07/2011 | WO2010131916A3 Sirna conjugate and preparation method thereof |
| 04/07/2011 | US20110083233 RICE BLAST SUSCEPTIBILITY GENE Pi21, RESISTANCE GENE pi21 AND USES THEREOF |
| 04/07/2011 | US20110083232 Maize microrna sequences |
| 04/07/2011 | US20110083231 Novel glyphosate-n-acetyltransferase (gat) genes |
| 04/07/2011 | US20110083230 Gene cluster involved in biosynthesis of isopentenyl diphosphate in the non-mevalonate pathway of hevea brasiliensis |
| 04/07/2011 | US20110083229 EG1117 And EG307 Polynucleotides And Uses Thereof |
| 04/07/2011 | US20110083202 Generation of haploid plants and improved plant breeding |
| 04/07/2011 | US20110082287 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene |
| 04/07/2011 | US20110082286 Method for Generating Aptamers with Improved Off-Rates |
| 04/07/2011 | US20110082283 Multimeric elp fusion constructs |
| 04/07/2011 | US20110082279 Chemiluminescent Compounds |
| 04/07/2011 | US20110082190 Nucleic Acids Encoding Anti-IL-12 Antibody |
| 04/07/2011 | US20110082186 Compositions for inhibiting gene expression and uses thereof |
| 04/07/2011 | US20110082185 Cancer-testis gene silencing agents and uses thereof |
| 04/07/2011 | US20110082095 Nucleic acids and corresponding proteins entitled 158p3d2 useful in treatment and detection of cancer |
| 04/07/2011 | US20110082094 Mammalian Cytokine-Like Polypeptide-10 |
| 04/07/2011 | US20110082093 Methods and compositions for treating trinucleotide repeat disorders |
| 04/07/2011 | US20110082090 Compounds suited as nanocarriers for active agents and their use |
| 04/07/2011 | US20110082078 Methods and compositions for treating neuropathies |
| 04/07/2011 | US20110082073 Modified Cpn10 and PRR signalling |
| 04/07/2011 | US20110082052 Phage displaying system expressing single chain antibody |
| 04/07/2011 | US20110082038 Eukaryotic translation initiation factor gene regulatory elements for use in plants |
| 04/07/2011 | US20110081717 Double-stranded nucleic acid molecule, cancer cell proliferation inhibitor and pharmaceutical agent suitable for prevention or treatment of cancer |
| 04/07/2011 | US20110081708 Method of Sequence Optimization for Improved Recombinant Protein Expression using a Particle Swarm Optimization Algorithm |
| 04/07/2011 | US20110081707 Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor |
| 04/07/2011 | US20110081705 Recombinant elastase proteins and methods of manufacturing and use thereof |
| 04/07/2011 | US20110081703 Chimeric isoprenoid synthases and uses thereof |
| 04/07/2011 | US20110081696 Polypeptides Having Cellobiohydrolase II Activity and Polynucleotides Encoding Same |
| 04/07/2011 | US20110081688 Water-Soluble Rhodamine Dyes Conjugates |
| 04/07/2011 | US20110081681 Human antibodies to human cd20 and method of using thereof |
| 04/07/2011 | US20110081678 Method for producing beta-alanyl-amino acid or derivative thereof |
| 04/07/2011 | US20110081661 Modified photoproteins with increased affinity for calcium and enhanced bioluminescence and uses thereof |
| 04/07/2011 | US20110081656 Secreted proteins and uses thereof |
| 04/07/2011 | US20110081454 Use and production of citrate-stable neutral metalloproteases |
| 04/07/2011 | US20110081374 Recombinant avian paramyxovirus vaccine and method for making and using thereof |
| 04/07/2011 | US20110081366 Immunostimulatory nucleic acid molecules |
| 04/07/2011 | US20110081363 Compositions and methods for biological sample storage |
| 04/07/2011 | US20110081360 Human G-Protein Chemokine Receptor (CCR5) HDGNR10 |
| 04/07/2011 | US20110081357 Chimeric Vaccine for Haemophilus Influenzae-Induced Disease |
| 04/07/2011 | US20110081353 Antibody against the csf-1 r |
| 04/07/2011 | US20110081352 Immunogenic peptides and methods of use for treating and preventing cancer |
| 04/07/2011 | US20110081348 Fungal signalling and metabolic enzymes |
| 04/07/2011 | US20110081347 Antibodies with Altered Binding to FcRn and Methods of Using Same |
| 04/07/2011 | US20110081346 B7 FAMILY MEMBER zB7H6 AND RELATED COMPOSITIONS AND METHODS |
| 04/07/2011 | US20110081343 Vaccines directed to langerhans cells |
| 04/07/2011 | US20110081342 Anti-vegf antibodies |
| 04/07/2011 | US20110079528 Oligonucleotide compositions and methods for treating disease including inflammatory conditions |
| 04/07/2011 | US20110079512 Primer and probe for detection of mycobacterium intracellulare, and method for detection of mycobacterium intracellulare using the primer or the probe |
| 04/07/2011 | CA2776534A1 Piscine reovirus diagnostic compositions |
| 04/06/2011 | EP2305813A2 Fuctional and hyperfunctional sirna |
| 04/06/2011 | EP2305812A2 Fuctional and hyperfunctional sirna |
| 04/06/2011 | EP2305809A2 Methods for nucleic acid isolation and kits using a microfluidic device and concentration step |